Syed Murtaza Ishaq

Syed Murtaza Ishaq

Auto-generated profile, based on publicly available information

Syed Murtaza Ishaq

Sinai Hospital of Baltimore/Lifebridgehealth, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
DYDevvrat Yadav
Devvrat Yadav
CSChiranjeevi Sainatham
Chiranjeevi Sainatham
EFEvgenii Filippov
Evgenii Filippov
SKSai Gautham Kanagala
Sai Gautham Kanagala
SISyed Murtaza Ishaq
Syed Murtaza Ishaq
Thejus JayakrishnanThejus Jayakrishnan
Thejus Jayakrishnan
Traditionally, the role of gut dysbiosis was thought to be limited to pathologies like Clostridioides difficile infection, but studies have shown its role in other intestinal and extraintestinal pathologies. Similarly, recent studies have surfaced showing the strong potential role of the gut microbiome in colorectal cancer, which was traditionally attributed mainly to sporadic or germline mutations. Given that it is the third most common cancer and the second most common cause of cancer-related mortality, 78 grants totaling more than USD 28 million have been granted to improve colon cancer management since 2019. Concerted efforts by several of these studies have identified specific bacterial consortia inducing a proinflammatory environment and promoting genotoxin production, causing the induction or progression of colorectal cancer. In addition, changes in the gut microbiome have also been shown to alter the response to cancer chemotherapy and immunotherapy, thus changing cancer prognosis. Certain bacteria have been identified as biomarkers to predict the efficacy of antineoplastic medications. Given these discoveries, efforts have been made to alter the gut microbiome to promote a favorable diversity to improve cancer progression and the response to therapy. In this review, we expand on the gut microbiome, its association with colorectal cancer, and antineoplastic medications. We also discuss the evolving paradigm of fecal microbiota transplantation in the context of colorectal cancer management.

15 October 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
ABAbdul Rasheed Bahar
Abdul Rasheed Bahar
YBYasemin Bahar
Yasemin Bahar
GKGeorge Kidess
George Kidess
PKPaawanjot Kaur
Paawanjot Kaur
SMSyed Ishaq Murtaza
Syed Ishaq Murtaza
MAM. Chadi Alraies
M. Chadi Alraies
Cardiogenic shock (CS) is a severe complication of ST-elevation myocardial infarction (STEMI) with high mortality despite advancements in treatment. Mechanical circulatory support (MCS) devices, such as extracorporeal membrane oxygenation, Impella, and intraaortic balloon pump, have shown promise in improving outcomes but remain underutilized, especially among minority populations and women. This study evaluated disparities in MCS utilization among STEMI-CS patients based on sex, race, and socioeconomic factors. We analyzed data from the Nationwide Inpatient Sample between 2016 and 2021, identifying patients with STEMI-CS using International Classification of Diseases, Tenth Revision codes. Patients were stratified based on MCS utilization. Sociodemographic and hospital characteristics were compared, and multivariate logistic regression and propensity score matching were applied to evaluate disparities and outcomes. Among 140,820 patients with STEMI-CS, 18.8% received MCS. MCS recipients were younger, predominantly male (74.2% vs 65.1%; P < .001), and more likely to be treated at urban teaching hospitals (81.8% vs 75%; P < .001). Female patients had 30% lower odds of receiving MCS (adjusted odds ratio [aOR], 0.70; 95% CI, 0.65-0.76; P < .001), while African American (aOR, 0.85; 95% CI, 0.75-0.97; P = .016) and Asian (aOR, 0.70; 95% CI, 0.58-0.85; P < .001) patients were less likely to receive MCS than White patients. Medicaid recipients and rural hospital patients also had reduced odds of MCS utilization. Subgroup analysis revealed racial disparities in MCS utilization among men but not women. MCS use was associated with longer hospital stays (9 vs 7 days) and higher costs ($433,201 vs $191,121). This study highlights significant disparities in MCS utilization among STEMI-CS patients, driven by sex, race, and socioeconomic factors. These findings underscore the need for targeted interventions to address health care inequities and improve outcomes in this high-risk population.

3 June 2025 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
ABAbdul Rasheed Bahar
Abdul Rasheed Bahar
YBYasemin Bahar
Yasemin Bahar
SISyed Murtaza Ishaq
Syed Murtaza Ishaq
AZAbubakr Ziaullah
Abubakr Ziaullah
PUPrakash Upreti
Prakash Upreti
MAM. Chadi Alraies
M. Chadi Alraies

18 May 2023 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
YSyasar sattar
yasar sattar
MHMohammad Hamza
Mohammad Hamza
BABandar Alyami
Bandar Alyami
NPNeel N. Patel
Neel N. Patel
FYFarah Yasmin
Farah Yasmin
MAM. Chadi Alraies
M. Chadi Alraies

28 August 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
ABAbdul Rasheed Bahar
Abdul Rasheed Bahar
YBYasemin Bahar
Yasemin Bahar
HAHafeezuddin Ahmed
Hafeezuddin Ahmed
SISyed M. Ishaq
Syed M. Ishaq
PKPaawanjot Kaur
Paawanjot Kaur
MAM. Chadi Alraies
M. Chadi Alraies
Disparities in health care access and utilization have been widely documented in cardiovascular interventions. The intra-aortic balloon pump (IABP), a critical mechanical circulatory device used in high-risk coronary artery bypass graft (CABG) patients, has shown significant variability in utilization across sociodemographic groups. This study examines the influence of social determinants of health, including sex, race, ethnicity, income, and insurance status, on IABP utilization prior to CABG. This retrospective cohort study utilized the Nationwide Inpatient Sample from 2016-2021 to identify patients undergoing CABG. IABP use was defined as preoperative utilization in patients awaiting CABG. Multivariable logistic regression analyzed the impact of sociodemographic factors on IABP use, adjusting for baseline comorbidities and hospital characteristics. Propensity score matching was employed to compare in-hospital outcomes between IABP and non-IABP groups. Statistical significance was set at P < .05. Of 471,985 CABG patients, IABP was utilized in 14,535 patients (3.1%) preoperatively. Adjusted analyses revealed significant disparities: women were less likely to receive IABP, while Hispanic and Asian patients were more likely to receive IABP compared to Whites. Medicaid coverage increased the odds of IABP use, whereas income quartiles showed no significant impact. Regional disparities were noted, with lower odds of IABP use in the South and West. Weekend admissions were associated with higher IABP utilization. Subgroup analysis identified higher IABP use among Hispanic men and women. Significant disparities in IABP utilization exist across sociodemographic and regional lines, with lower use among women and patients in the South and West regions, and higher use among Hispanic and Asian patients. These findings underscore the presence of sex-based disparities and significant variation in racial/ethnic patterns of IABP utilization, highlighting the need for further investigation and targeted interventions to ensure equitable application of advanced cardiovascular therapies.